Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
15 studies found for:    diabetes and eye and open and active | Open Studies
Show Display Options
RSS Create an RSS feed from your search for:
diabetes and eye and open and active | Open Studies
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Metabolomics in Surgical Ophthalmological Patients
Conditions: Primary Open-angle Glaucoma;   Low Tension Glaucoma
Intervention: Diagnostic Test: Metabolomics analysis of patient samples
2 Recruiting Safety and Efficacy of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
Conditions: Glaucoma, Open-Angle;   Ocular Hypertension
Interventions: Drug: Bimatoprost sustained-release;   Other: Sham;   Drug: Timolol;   Drug: Timolol Vehicle (placebo)
3 Recruiting Endolaserless Vitrectomy With Intravitreal IAI for PDR-Related VH
Condition: Proliferative Diabetic Retinopathy
Interventions: Drug: Aflibercept;   Procedure: Endolaserless Vitrectomy
4 Recruiting Validation of an Integrated Attention Model for Patients With Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Behavioral: CAIPaDi
5 Recruiting PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs
Conditions: DIABETES;   DIABETIC RETINOPATHY;   DIABETIC NEUROPATHY
Intervention: Drug: CHOLESTYRAMINE
6 Recruiting Electrophysiologic Changes in Blacks Treated With CBT for Insomnia
Condition: Insomnia
Interventions: Behavioral: Cognitive Behavioral Therapy for Insomnia (CBT-I);   Behavioral: Self-Monitoring
7 Recruiting Noctura400 Treatment for Diabetic Retinopathy (CANDLE)
Condition: Diabetic Macular Oedema
Interventions: Device: Noctura 400 Eye Mask;   Drug: Ranibizumab
8 Recruiting Endo-nasal Endoscopic DCR and External-DCR in Primary Nasolacrimal Duct Obstruction
Condition: Primary Acquired Nasolacrimal
Interventions: Procedure: Endoscopic DCR;   Procedure: External DCR
9 Recruiting Early Sleeve Gastrectomy In New Onset Diabetic Obese Patients
Condition: Type 2 Diabetes Mellitus
Interventions: Procedure: LSG;   Drug: CMT
10 Recruiting Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab
Conditions: Visual Acuity Reduced Transiently;   Macular Edema, Cystoid
Intervention: Drug: ranibizumab
11 Not yet recruiting Ranibizumab for Edema of the mAcula in Diabetes: Protocol 4 With Tocilizumab: The READ-4 Study
Condition: Diabetic Macular Edema
Interventions: Drug: Tocilizumab;   Drug: Ranibizumab
12 Recruiting CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea
Conditions: Diabetic Retinopathy;   Sleep Apnea
Interventions: Device: Continuous positive airway pressure;   Drug: Pharmacological treatment;   Other: Conventional anti-diabetic diet recommendations
13 Recruiting Aflibercept anD navigateD vErsus coNvensional Laser in Diabetic macUlar edeMa
Condition: Diabetic Macular Oedema
Interventions: Device: Navigated laser;   Device: Conventional laser
14 Recruiting Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection
Conditions: Neovascularization;   Macular Degeneration;   Diabetic Retinopathy;   Retinal Vein Occlusion;   Choroidal Neovascularization;   Retinal Neovascularization;   Recurrent Pterygium;   Cystoid Macular Edema
Intervention: Drug: ziv-aflibercept
15 Recruiting Study of Management of Pasireotide-induced Hyperglycemia in Adult Patients With Cushing's Disease or Acromegaly
Conditions: Cushing's Disease;   Acromegaly
Interventions: Drug: Pasireotide s.c.;   Drug: Sitagliptin;   Drug: Liraglutide;   Drug: Insulin;   Drug: Pasireotide LAR;   Drug: Metformin

Study has passed its completion date and status has not been verified in more than two years.